NEW YORK (GenomeWeb News) - Helicos BioSciences said today that it has shipped a Helicos Genetic Analysis System to Stanford University, marking the company’s second shipment to a customer site.
Helicos said in August that it had received an order from a US cancer research center that will use the instrument for research into cancer stem cell biology. A company spokesperson told GenomeWeb Daily News sister publication In Sequence today that this order came from Stanford University.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.